First-pass metabolism occurs with which route?
First-pass metabolism primarily occurs with the oral route.
When a drug is administered orally, it is absorbed through the gastrointestinal tract and then transported to the liver via the portal vein. This initial metabolism in the liver can significantly reduce the concentration of the drug before it reaches systemic circulation, a phenomenon known as first-pass metabolism.
Subcutaneous administration involves injecting a drug into the fatty tissue just beneath the skin. While this route allows for absorption into the bloodstream, it bypasses the gastrointestinal tract and liver initially, thus avoiding first-pass metabolism. The drug enters systemic circulation more directly, leading to higher bioavailability compared to oral administration.
As previously mentioned, oral administration is subject to first-pass metabolism because the drug is absorbed through the digestive system and processed by the liver before reaching systemic circulation. This metabolic process can significantly alter the drug's efficacy, making oral administration the route most commonly associated with first-pass effects.
Intramuscular injections deliver medications directly into muscle tissue, where they are absorbed into the bloodstream. Similar to subcutaneous routes, intramuscular administration does not involve the gastrointestinal tract and liver until after the drug enters systemic circulation, thereby avoiding first-pass metabolism.
Intravenous administration delivers a drug directly into the bloodstream, providing immediate systemic availability. Since there is no passage through the gastrointestinal tract or liver before entering circulation, intravenous routes completely bypass first-pass metabolism, ensuring the full dose of the drug reaches the systemic circulation.
First-pass metabolism is a significant pharmacokinetic phenomenon that primarily occurs with oral drug administration, as the liver metabolizes a portion of the drug before it reaches systemic circulation. In contrast, subcutaneous, intramuscular, and intravenous routes bypass this initial metabolic processing, allowing for greater drug bioavailability. Understanding these differences is crucial for optimizing drug delivery and therapeutic effectiveness.
Related Questions
View allTrade name for olmesartan?
Oral preparation in sweetened alcohol vehicle =
Cimetidine 400 mg tablet b.i.d. â†' liquid 300 mg/5 mL. Volume per...
Lactulose syrup 1 tbsp PO t.i.d. Daily volume in mL?
Expired product check frequency set by:
Related Quizzes
View allPharmacy Technician Certification Exam PTCE
PTCE Pharmacy Technician Certification Exam
PTCE Blue Print for Pharmacy Technician Certification
Pharmacy Technician Certification Exam PTCE Blueprint
Master The Pharmacy Technician Certification Exam PTCE
Pharmacy Technician Certification Exam Answers
PTCE With Online Test Pharmacy Technician Certification Exam
Certified Pharmacy Technician Certification
Pharmacy Technician Certification Board Practice Exam
Pharmacy Technician Certification Exam Practice Test
- ✓ 500+ Practice Questions
- ✓ Detailed Explanations
- ✓ Progress Analytics
- ✓ Exam Simulations